MAP3K1 and systemic lupus erythematosus: After MSC transplantation, levels of circulating miR-320b and MAP3K1 significantly decreased, which helped alleviate SLE symptoms and inhibited CD4+ T cell proliferation in MRL/lpr mice [15].